Medicine
Endothelial Glycocalyx Degradation in Sepsis and Therapeutic Targeting
Quick fact
Within just 30 minutes of sepsis onset, up to 60% of the endothelial glycocalyx can be shed, releasing its components (like syndecan-1) into the blood, which are now used as biomarkers of severity.
Why this is interesting
Your blood vessels are lined with a microscopic, sugar-coated 'fuzz' that keeps fluid inside—but during sepsis, this protective layer is stripped away within hours. Why does this happen, and can we stop it?
Read the full explanation
Understanding Endothelial Glycocalyx Degradation in Sepsis and Therapeutic Targeting
Imagine the inside of your blood vessels as a velvet-lined tube. The 'velvet' is the endothelial glycocalyx—a mesh of sugar chains (heparan sulfate, hyaluronic acid) and proteins (like syndecan-1) that covers the cells lining the vessels (endothelial cells). This layer is not just a passive coating; it serves as a barrier, a sensor, and a cushion. It prevents water and proteins from leaking out, keeps blood cells from sticking to the vessel wall, and plays a role in controlling blood flow. In sepsis—a severe, whole-body reaction to an infection—this 'velvet' is violently torn off. The immune system, in a desperate attempt to fight the infection, releases a flood of enzymes (like matrix metalloproteinases and heparanase) that chew up the glycocalyx. Also, inflammatory molecules (such as tumor necrosis factor-alpha) cause the endothelial cells to actively shed pieces of the glycocalyx. The result is a bare, sticky vessel wall. Once the glycocalyx is gone, the vessel becomes leaky: water and proteins pour out into the tissues, causing swelling (edema). White blood cells, which are supposed to stay in the bloodstream until needed, now stick abundantly to the wall and migrate into tissues, causing inflammation. The vessel tone is also impaired, leading to low blood pressure and inadequate blood flow to organs—hallmarks of septic shock and organ failure.
A deeper explanation
The glycocalyx is a dynamic structure in constant equilibrium: it is continuously synthesized and shed. In sepsis, this balance is tipped dramatically toward degradation. The key inducers are inflammatory cytokines (e.g., TNF-α, IL-1β) and reactive oxygen species (ROS), which activate several enzyme families: - Matrix metalloproteinases (MMPs): These enzymes cleave the protein core of proteoglycans (like syndecan-1) and degrade the carbohydrate side chains. - Heparanase: This enzyme specifically cleaves heparan sulfate chains, breaking the glycocalyx scaffold. - Hyaluronidases: These degrade hyaluronic acid, another major glycosaminoglycan component. Additionally, the endothelial cells themselves 'shed' whole membrane-bound structures by activating specific enzymes (sheddases) that cut the protein anchors. The consequence is a cascade: loss of glycocalyx → increased vascular permeability → tissue edema → compromised microcirculation (red blood cells can no longer deform and pass through capillaries easily because the glycocalyx normally helps them slide through) → local hypoxia → further inflammation and organ dysfunction. Why is this important? The extent of glycocalyx degradation correlates with the severity of sepsis and mortality. This makes the glycocalyx a key biomarker (e.g., soluble syndecan-1 in blood) and a target for therapy. Therapeutic strategies aim to protect the glycocalyx or restore it: - Corticosteroids: have been shown to reduce glycocalyx shedding. - Antioxidants: like vitamin C, can scavenge ROS and reduce enzyme activation. - Inhibitors of specific enzymes: such as MMP inhibitors or heparanase inhibitors, are under investigation. - Glycocalyx precursors: like sulodexide or hyaluronic acid analogues, to replenish the layer. - Fluid therapy: cautious because over-resuscitation can damage the glycocalyx further. This concept is central to understanding why sepsis causes such severe vascular dysfunction, and it opens up a promising avenue for targeted therapies that could improve outcomes beyond current antibiotic and supportive care.